Edgar Tracker

NEUP Neuphoria Therapeutics Inc.

Nasdaq · CIK 1191070 · Pharmaceutical Preparations

SEC company page

Public articles

No public articles yet. Follow NEUP to track filings and write notes.

Recent filings

–

Form Filed Title Accession
8-K2026-10-231.01 Entry into a Material Definitive Agreement · 3.03 Material Modification to Rights of Security Holders · 9.01 Financial Statements and Exhibits0001213900-26-111863
SCHEDULE 13G2026-10-05—0000929638-26-003845
DEFA14A2026-09-18DEFA14A0001140361-26-037146
DEFA14A2026-09-18DEFA14A0001140361-26-037144
DEF 14A2026-09-18DEF 14A0001140361-26-037139
10-K2026-09-1810-K0001193125-26-395536
SCHEDULE 13G/A2026-07-28—0001104659-26-087379
DEFA14A2026-07-24CURRENT REPORT0001213900-26-081054
8-K2026-07-241.01 Entry into a Material Definitive Agreement · 5.01 Changes in Control of Registrant · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits0001213900-26-081052
8-K2026-05-268.01 Other Events0001213900-26-061028
10-Q2026-05-1510-Q0001193125-26-225442
10-Q2026-02-1710-Q0001193125-26-054509
SCHEDULE 13G/A2026-02-06—0001957912-26-000007
8-K2026-01-081.01 Entry into a Material Definitive Agreement · 1.02 Termination of a Material Definitive Agreement · 9.01 Financial Statements and Exhibits0001213900-26-002245
SCHEDULE 13D/A2025-12-29—0000905148-25-004490
8-K2025-12-183.01 Notice of Delisting or Failure to Satisfy Listing Rule0001213900-25-123289
8-K2025-12-175.07 Submission of Matters to a Vote of Security Holders0001213900-25-122777
DFAN14A2025-12-08DFAN14A0001193125-25-311436
DFAN14A2025-12-08DFAN14A0001193125-25-311358
DEFA14A2025-12-08DEFINITIVE ADDITIONAL MATERIALS0001213900-25-119241